GFAP and Alzheimer disease: In the context of glial cell activation, the GFAP-IL6 mouse model, which overexpresses IL-6 in astrocytes, demonstrates chronic neuroinflammation accompanied by significant neurodegeneration and cognitive decline, highlighting the pivotal role of astrocyte-derived IL-6 in AD [239].